Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dana Farengo Clark

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the National Cancer Institute|December 17, 2019
CDH1 on Multigene Panel Testing: Look Before You LeapBryson W Katona, Dana Farengo Clark, Susan M Domchek
JCO Precision Oncology|November 12, 2022
Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal CancerSarah E Coughlin, Brandie Heald, Dana Farengo Clark, et al.
JCO Precision Oncology|September 13, 2019
Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic SequencingDana Farengo Clark, Kara N Maxwell, Jacquelyn Powers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 14, 2020
Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancerDana Farengo Clark, Scott T Michalski, Rashmi Tondon, et al.
Cancer Genetics|April 27, 2024
Clinical management of TP53 mosaic variants found on germline genetic testingAbigail Ward, Dana Farengo-Clark, Danielle B McKenna, et al.
The American Journal of Gastroenterology|September 10, 2022
Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter AnalysisPeter P Stanich, Dareen Elgindi, Elena Stoffel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Journal of Medical Genetics|August 29, 2022
First estimates of diffuse gastric cancer risks for carriers of <i>CTNNA1</i> germline pathogenic variantsMarie Coudert, Youenn Drouet, Hélène Delhomelle, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 10, 2014
Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibilityAngela R Bradbury, Linda Patrick-Miller, Jessica Long, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the National Cancer Institute|December 17, 2019
CDH1 on Multigene Panel Testing: Look Before You LeapBryson W Katona, Dana Farengo Clark, Susan M Domchek
JCO Precision Oncology|November 12, 2022
Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal CancerSarah E Coughlin, Brandie Heald, Dana Farengo Clark, et al.
JCO Precision Oncology|September 13, 2019
Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic SequencingDana Farengo Clark, Kara N Maxwell, Jacquelyn Powers, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 14, 2020
Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancerDana Farengo Clark, Scott T Michalski, Rashmi Tondon, et al.
Cancer Genetics|April 27, 2024
Clinical management of TP53 mosaic variants found on germline genetic testingAbigail Ward, Dana Farengo-Clark, Danielle B McKenna, et al.
The American Journal of Gastroenterology|September 10, 2022
Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter AnalysisPeter P Stanich, Dareen Elgindi, Elena Stoffel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 21, 2026
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 VariantsGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in <i>BRCA1/2</i> CarriersGiulia Ongaro, Caroline Salafia, Rania Sheikh, et al.
Journal of Medical Genetics|August 29, 2022
First estimates of diffuse gastric cancer risks for carriers of <i>CTNNA1</i> germline pathogenic variantsMarie Coudert, Youenn Drouet, Hélène Delhomelle, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 10, 2014
Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibilityAngela R Bradbury, Linda Patrick-Miller, Jessica Long, et al.
Pageof 2